-
Concordia International Corp. Executes Support Agreement and Obtains Interim Order in Connection with its Recapitalization Transaction, and Announces Leadership Transition
-
Concordia International Corp. Announces Fourth Quarter and Fiscal 2017 Results
-
Concordia International (CXRX) Comments on CMA Statement of Objections Related to Liothyronine
-
Concordia International Corp. Comments on CMA Statement of Objections Related to Liothyronine
-
Concordia International Corp. Announces Third Quarter 2017 Results
-
Concordia International (CXRX) Seeks Debt Restructuring Under the Canada Business Corporations Act
-
Concordia International Corp. Takes Next Step to Realign Its Capital Structure By Commencing Proceedings Under the Canada Business Corporations Act
-
Concordia (CXRX) Defers Unsecured Interest Payment Due October 16, Continues Talks with Stakeholders
-
Concordia International Corp. Continues Discussions with Stakeholders; Defers Unsecured Interest Payment Due October 16th as It Works Toward Realignment of its Capital Structure

